Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab subject-tailored dosing in plaque psoriasis
NCT01550744Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2012
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ustekinumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Mar 2012; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01550744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01550744.